Simvastatin Inhibits Renal Cancer Cell Growth and Metastasis via AKT/mTOR, ERK and JAK2/STAT3 Pathway

• Zhiqing Fang,

  Affiliations Department of Urology, Qilu Hospital of Shandong University, Ji'nan, Shandong, China, The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education and Chinese Ministry of Public Health, Qilu Hospital of Shandong University, Ji'nan, Shandong, China

  ⨯
• Yueqing Tang,

  Affiliation Department of Urology, Qilu Hospital of Shandong University, Ji'nan, Shandong, China

  ⨯
• Juanjuan Fang,

  Affiliation Department of Anesthesiology, Wucheng People's Hospital, Wucheng, Shandong, China

  ⨯
• Zunlin Zhou,

  Affiliation Department of Urology, Qilu Hospital of Shandong University, Ji'nan, Shandong, China

  ⨯
• Zhaoquan Xing,

  Affiliation Department of Urology, Qilu Hospital of Shandong University, Ji'nan, Shandong, China

  ⨯
• Zhaoxin Guo,

  Affiliation Department of Urology, Qilu Hospital of Shandong University, Ji'nan, Shandong, China

  ⨯
• Xiaoyu Guo,

  Affiliation School of Nursing, Shandong University, Jinan, Shandong, China

  ⨯
• Weichang Wang,

  Affiliation Department of Urology, Qilu Hospital of Shandong University, Ji'nan, Shandong, China

  ⨯
• Wei Jiao,

  Affiliation Department of Urology, Qilu Hospital of Shandong University, Ji'nan, Shandong, China

  ⨯
• Zhonghua Xu,

  Affiliation Department of Urology, Qilu Hospital of Shandong University, Ji'nan, Shandong, China

  ⨯
• Zhaoxu Liu

  * E-mail: zhaoxvl@sdu.edu.cn

  Affiliations Department of Urology, Qilu Hospital of Shandong University, Ji'nan, Shandong, China, School of Nursing, Shandong University, Jinan, Shandong, China

  ⨯